leisure time -WSS

leisure time

author：hotspot 2025-10-02 01:12:29 - browse：62485

BRENDAN SMIALOWSKI/AFP via Getty Images

A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. Under her leadership, Stimwave distorted the design of the device to better fit insurance codes, resulting in unnecessary plastic components that allowed the company to sell its products for thousands of dollars more than it otherwise could. From 2017 to 2020, the company sold nearly 8,000 devices with the non-functioning component.

STAT published new details about the Stimwave story last May, after former employees described how Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： 3 questions for the future of Biden's cancer moonshot

explore

hotspot

WSS

STAT reporters are Pulitzer Prize finalists for investigative reporting

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

The future of health care in the House

Colorectal cancer study finds potential in overlooked immune cell

Fertility clinic egg and embryo storage is a disaster

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

hotspot

leisure time

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Novavax promises a turnaround & Lilly roils the obesity market

Galapagos to make CAR

Novavax promises a turnaround & Lilly roils the obesity market

The future of health care in the House

Continuity nursing helped my family in our darkest PICU moments

Novo Nordisk testing Wegovy against alcohol

Cancer drug shortages should be causing more outrage

STAT series 'Denied by AI' wins major journalism prizes

hotspot

VC firm General Catalyst wants to buy a health system

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Chemotherapy drug shortage eases slightly but still widespread

ALS treatment from Biogen, Ionis fails in study

hotspot

explore

hotspot

focus